P2X7 Antibodies

Santa Cruz Biotechnology offers a broad range of P2X7 monoclonal antibodies for research focused on understanding P2X7 receptor functions. P2X7 monoclonal antibodies are compatible with multiple experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The P2X7 receptor is a crucial component of the purinergic signaling pathway, playing a significant role in immune responses and inflammation. P2X7 receptors mediate the release of pro-inflammatory cytokines and are implicated in various pathological conditions, including chronic pain, neurodegenerative diseases, and cancer. Understanding P2X7 receptor function is essential for developing targeted therapies and advancing knowledge of cellular communication. Researchers worldwide utilize P2X7 monoclonal antibodies to investigate receptor distribution across different tissues and cell types. Advanced visualization techniques with P2X7 monoclonal antibodies enable detailed examination of receptor localization and trafficking within cells. Multiple conjugation options, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), provide flexibility in experimental design. Santa Cruz Biotechnology monoclonal antibodies for P2X7 research contribute to advancing scientific understanding of cellular signaling pathways and potential therapeutic targets.